These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The current status of antiobesity drugs. Galloway SM, Farquhar DL, Munro JF. Postgrad Med J; 1984; 60 Suppl 3():19-26. PubMed ID: 6393107 [Abstract] [Full Text] [Related]
3. [Value and danger of drugs prescribed in obesity]. Lumbroso P. Therapeutique; 1971; 47(6):635-8. PubMed ID: 5571185 [No Abstract] [Full Text] [Related]
4. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR. J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225 [Abstract] [Full Text] [Related]
5. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice]. Geyer G, Haidinger G, Francesconi M, Langmayr N, Prager R, Schoberberger R, Toplak H, von Kalckreuth G, Kunze M. Acta Med Austriaca; 1995 Jan; 22(5):95-101; 104-9. PubMed ID: 8651045 [Abstract] [Full Text] [Related]
6. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group. J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224 [Abstract] [Full Text] [Related]
7. A close look at fenfluramine and dexfenfluramine. Vivero LE, Anderson PO, Clark RF. J Emerg Med; 1998 Jan; 16(2):197-205. PubMed ID: 9543401 [Abstract] [Full Text] [Related]
8. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group]. Héraïef E. Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531 [Abstract] [Full Text] [Related]
9. [Rôle of anorectic agents and other drugs in treatment of obesity]. Laurent LP. Vie Med Can Fr; 1972 May; 1(5):491-3. PubMed ID: 4643642 [No Abstract] [Full Text] [Related]
13. [Drug therapy of obesity]. Cairella M. Clin Ter; 1978 Mar 31; 84(6):571-92. PubMed ID: 648107 [No Abstract] [Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, Zanella MT, Coutinho W. Arch Gen Psychiatry; 2003 Nov 31; 60(11):1109-16. PubMed ID: 14609886 [Abstract] [Full Text] [Related]
15. Evaluation of dexfenfluramine in a weight loss program for obese infertile women. Galletly C, Clark A, Tomlinson L. Int J Eat Disord; 1996 Mar 31; 19(2):209-12. PubMed ID: 8932560 [Abstract] [Full Text] [Related]
16. [Mode of action and indication for appetite depressants in the treatment of obesity]. Stauffacher W. Schweiz Med Wochenschr; 1975 Apr 12; 105(15):461-6. PubMed ID: 1124373 [Abstract] [Full Text] [Related]